Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer (EPIDROP)

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

August 31, 2025

Study Completion Date

October 31, 2025

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

Blood sample

Twenty ml of blood will be drawn from each patient : 10 ml of blood will be drawn on CellSave tubes (fixed cells) for CTC detection using the FDA-cleared CellSearch system (gold standard) and 10 ml of blood will be drawn on EDTA tubes (viable cells) for the detection of functional CTCs using the EPIDROP.

Trial Locations (2)

34295

ACTIVE_NOT_RECRUITING

University Hospital Center, Montpellier

Unknown

RECRUITING

University Center, Hospital, Nîmes

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER